M
Maxime Dougados
Researcher at University of Paris
Publications - 1144
Citations - 78022
Maxime Dougados is an academic researcher from University of Paris. The author has contributed to research in topics: Rheumatoid arthritis & Ankylosing spondylitis. The author has an hindex of 134, co-authored 1054 publications receiving 69979 citations. Previous affiliations of Maxime Dougados include French Institute of Health and Medical Research & Paris Descartes University.
Papers
More filters
Journal ArticleDOI
Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort
Ho Yin Chung,Pedro Machado,Désirée Van Der Heijde,Maria Antonietta D'Agostino,Maxime Dougados +4 more
TL;DR: In early axial SpA patients, smoking was independently associated with earlier onset of IBP, higher disease activity, increase axial inflammation on MRI, increased axial structural damage on MRI and radiographs, poorer functional status and poorer quality of life.
Journal ArticleDOI
Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis : can assessment of spinal mobility be a proxy for radiographic evaluation?
Alkwin Wanders,Robert Landewé,Maxime Dougados,Herman Mielants,Sj van der Linden,D. van der Heijde +5 more
TL;DR: This study unequivocally demonstrated a relationship between spinal mobility and radiographic damage, however, spinal mobility cannot be used as a proxy for radiographic evaluation in an individual patient.
Journal ArticleDOI
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis.
Andreas Kerschbaumer,Alexandre Sepriano,Alexandre Sepriano,Josef S Smolen,Désirée van der Heijde,Maxime Dougados,Ronald F van Vollenhoven,Iain B. McInnes,Johannes W. J. Bijlsma,Gerd R Burmester,Maarten de Wit,Louise Falzon,Robert Landewé +12 more
TL;DR: This SLR informed the task force regarding the evidence base of various therapeutic regimen for the development of the update of EULAR’s RA management recommendation.
Journal ArticleDOI
Efficacy of infliximab in refractory ankylosing spondylitis: results of a six‐month open‐label study
Maxime Breban,E. Vignon,P. Claudepierre,Valérie Devauchelle,D. Wendling,E. Lespessailles,Liana Euller-Ziegler,Jean Sibilia,Aleth Perdriger,M. Mezières,C. Alexandre,Maxime Dougados +11 more
TL;DR: This study confirms the remarkable efficacy of infliximab in a large group of severely affected AS patients, and almost one-third of completers were still free of relapse 4 months after the last infusion.
Journal ArticleDOI
Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study
Astrid van Tubergen,Sofia Ramiro,Désirée van der Heijde,Maxime Dougados,Herman Mielants,Robert Landewé +5 more
TL;DR: In AS, patients with existing syndesmophytes are prone to develop new Syndesmophyte formation over time, and older age, worse functional status, male gender, erythrocyte sedimentation rate and existing syndmophytes were associated with development of new syndsmophytes at 4 years.